Nitric oxide inhibits HIV Tat-induced NF-κB activation

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 275-284

  Chen, Fei ^a   Lu, Yongju ^a   Castranova, Vince ^a   Rojanasakul, Yon ^b   Miyahara, Kaoru ^c   Shizuta, Yutaka ^c   Vallyathan, Val ^a   Shi, Xianglin ^a   Demers, Laurence M ^d  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS GENE;

EID: 0033021102     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65121-8     Document Type: Article

References (56)

1. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997, 100:2417-2423
2. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350
3. Guidotti LG, Chisari FV: To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996, 8:478-483
4. Tucker PC, Griffin DE, Choi S, Bui N, Wesselingh S: Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol 1996, 70:3972-3977
5. Peterhans E: Reactive oxygen species and nitric oxide in viral diseases. Biol Trace Element Res 1997, 56:107-116
6. Karupiah G, Harris N: Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites. J Exp Med 1995, 181:2171-2179
7. Bi Z, Reiss CS: Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 1995, 69:2208-2213
8. Guillemard E, Geniteau-Legendre M, Kergot R, Lemaire G, Petit JF, Labarre C, Quero AM: Activity of nitric oxide-generating compounds against encephalomyocarditis virus. Antimicrobial Agents Chemother 1996, 40:1057-1059
9. Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL: Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 1997, 71:5227-5235
10. Melkova Z, Esteban M: Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase. J Immunol 1995, 155: 5711-5718
11. Harris N, Buller RM, Karupiah G: Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 1995, 69:910-915
12. Torre D, Ferrario G: Immunological aspects of nitric oxide in HIV-1 infection. Med Hypotheses 1996, 47:405-407
13. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921
14. Bukrinsky M, Schmidtmayerova H, Zybarth G, Dubrovsky L, Sherry B, Enikolopov G: A critical role of nitric oxide in human immunodeficiency virus type 1-induced hyperresponsiveness of cultured monocytes. Mol Med 1996, 2:460-468
15. Chen F, Sun SC, Kuhn DC, Gaydos LJ, Demers LM: Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 1995, 214: 985-992
16. Chen F, Kuhn DC, Sun SC, Gaydos LJ, Demers LM: Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages Biochem Biophys Res Commun 1995, 214:839-846
17. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of lκBα. J Biol Chem 1997, 272:30969-30974
18. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA: Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 1997, 132:1177-1183
19. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, Dawson VL: Neuronal (type I) nitric oxide synthase regulates nuclear factor kappa B activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci USA 1997, 94:2676-2680
20. Park SK, Lin HL, Murphy S: Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J 1997, 322:609-613
21. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM: Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 1996, 93:9114-9119
22. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT: Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res 1996, 24: 2236-2242
23. Chen F, Castranova V, Shi X, Demers LM: New insights into the role of NF-κB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999, 45:7-17
24. Webber EM, Bruix J, Pierce RH, Fausto N: Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998, 28:1226-1234
25. Baldwin AS Jr. The NF-κB and lκB proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683
26. Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA: Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain antibodies and NF-κB antagonists. J Virol 1997, 71:6486-6494
27. Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J: Transdominant mutants of lκBα block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J Virol 1996, 70:5777-5785
28. Harhaj E, Blaney J, Millhouse S, Sun SC: Differential effects of lκB molecules on Tat-mediated transactivation of HIV-1 LTR. Virology 1996, 216:284-287
29. Alcami J, Lain de Lera T, Folgueira L, Pedraza MA, Jacque JM, Bachelerie F, Noriega AR, Hay RT, Harrich D, Gaynor RB: Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995, 14:1552-1560
30. Chen F, Lu Y, Kuhn DC, Maki M, Shi X, Sun SC, Demers LM: Calpain contributes to silica-induced lκBα degradation and nuclear factor-κB activation. Arch Biochem Biophys 1997, 342:383-388
31. Wariishi S, Miyahara K, Toda K, Ogoshi S, Doi Y, Ohnishi S, Mitsui Y, Yui Y, Kawai C, Shizuta Y: A SP1 binding site in the GC-rich region is essential for a core promoter activity of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1995, 216: 729-735
32. Murphy KM, Sweet MJ, Ross IL, Hume DA: Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. J Virol 1993, 67:6956-6964
33. Sweet MJ, Hume DA: RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-α or taxol. J Inflamm 1995, 45(2):126-135
34. Munoz-Fernandez MA, Navarro J, Garcia A, Punzon C, Fernandez-Cruz E, Fresno M: Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-κB activation J Allergy Clin Immunol 1997, 100:838-845
35. Chen F, Kuhn DC, Gaydos LJ, Demers LM: Induction of nitric oxide and nitric oxide synthase mRNA by silica and lipopolysaccharide in PMA-primed THP-1 cells. APMIS 1996, 104:176-182
36. Kim IY, Stadtman TC: Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci USA 1997, 94:12904-12907
37. Chao CC, Lokensgard JR, Sheng WS, Hu S, Peterson PK: IL-1-induced iNOS expression in human astrocytes via NF-κB. Neuroreport 1997, 8:3163-3166
38. Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C, Bravo R: Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50. J Exp Med 1998, 187:985-996
39. Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, Philippon V, Thomson D, Vigne R, Wright A: Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 1993, 53:1-6
40. Rice WG, Schaeffer CA, Graham L, Bu M, McDougal JS, Orloff SL, Villinger F, Young M, Oroszlan S, Fesen MR: The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc Natl Acad Sci USA 1993, 90:9721-9724
41. Rice WG, Schaeffer CA, Harten B, Villinger F, South TL, Summers MF, Henderson LE, Bess JW Jr, Arthur LO, McDougal JS: Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 1993, 361:473-475
42. Sekkai D, Aillet F, Israel N, Lepoivre M: Inhibition of NF-κB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J Biol Chem 1998, 273:3895-3900
43. Kwon H, Pelletier N, DeLuca C, Genin P, Cisternas S, Lin R, Wainberg MA, Hiscott J: Inducible expression of lκBα represser mutants interferes with NF-κB activity and HIV-1 replication in jurkat T cells. J Biol Chem 1998, 273:7431-7440
44. Karupiah G, Chen JH, Mahalingam S, Nathan CF, MacMicking JD: Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase-2-deficient mice. J Exp Med 1998, 188:1541-1546
45. Zaragoza C, Ocampo C, Saura M, Leppo M, Wei XQ, Quick R, Moncada S, Liew FY, Lowenstein CJ: The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci USA 1998, 95:2469-2474
46. Karupiah G, Chen JH, Nathan CF, Mahalingam S, MacMicking JD: Identification of nitric oxide synthase-2 as an innate resistance locus against ectromelia virus infection. J Virol 1998, 72:7703-7706
47. MacLean A, Wei XQ, Huang FP, Al-Alem UA, Chan WL, Liew FY: Mice lacking inducible nitric oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol 1998, 79:825-830
48. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A: Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 1996, 97:1837-1843
49. Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA: Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 1995, 69:7001-7005
50. Kawanishi M: Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV. Intervirology 1995, 38:206-213
51. Kwon NS, Stuehr DJ, Nathan CF: Inhibition of tumor cell ribonucleotide reductase by macrophage derived nitric oxide. J Exp Med 1991, 174:761-768
52. Saura M, Zaragoza C, McMillan A, Quick RA, Hohenadl C, Lowenstein JM, Lowenstein CJ: An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999, 10:21-28
53. Bolanos JP, Peuchen S, Heales SJ, Land JM, Clark JB: Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 1994, 63:910-916
54. Perno CF, Crowe SM, Kornbluth RS: A continuing enigma: the role of cells of macrophage lineage in the development of HIV disease. J Leukocyte Biol 1997, 62:1-3
55. Magnani M, Rossi L, Fraternale A, Casabianca A, Brandi G, Benatti U, De Flora A: Targeting antiviral nucleotide analogues to macrophages. J Leukocyte Biol 1997, 62:133-137
56. Montaner LJ, Herbein G, Gordon S: Regulation of macrophage activation and HIV replication. Adv Exp Med Biol 1995, 374:47-56